Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C8H11N3O3.H2O |
Molecular Weight | 215.2065 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O.CC(=O)N[C@@H](CC1=CNC=N1)C(O)=O
InChI
InChIKey=PSWSDQRXCOJSFC-FJXQXJEOSA-N
InChI=1S/C8H11N3O3.H2O/c1-5(12)11-7(8(13)14)2-6-3-9-4-10-6;/h3-4,7H,2H2,1H3,(H,9,10)(H,11,12)(H,13,14);1H2/t7-;/m0./s1
Molecular Formula | C8H11N3O3 |
Molecular Weight | 197.1912 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Molecular Formula | H2O |
Molecular Weight | 18.0153 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Ultraviolet spectrophotometric characterization of copper(II) complexes with imidazole N-methyl derivatives of L-histidine in aqueous solution. | 2003 Jan 1 |
|
Histidine nutrition and genotype affect cataract development in Atlantic salmon, Salmo salar L. | 2005 Jun |
|
Kinetic analysis of the role of histidine chloramines in hypochlorous acid mediated protein oxidation. | 2005 May 17 |
|
Solution interactions between the uranyl cation [UO2(2+)] and histidine, N-acetyl-histidine, tyrosine, and N-acetyl-tyrosine. | 2009 Jan |
|
Prostate cancer-targeted imaging using magnetofluorescent polymeric nanoparticles functionalized with bombesin. | 2010 Apr |
|
Influence of histidine on the release of all-trans retinoic acid from self-assembled glycol chitosan nanoparticles. | 2010 Jul |
|
Ability of hypochlorous acid and N-chloramines to chlorinate DNA and its constituents. | 2010 Jul 19 |
|
Tumor targeting efficiency of bare nanoparticles does not mean the efficacy of loaded anticancer drugs: importance of radionuclide imaging for optimization of highly selective tumor targeting polymeric nanoparticles with or without drug. | 2010 Oct 15 |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 01:04:42 GMT 2023
by
admin
on
Sat Dec 16 01:04:42 GMT 2023
|
Record UNII |
PQ2TC3X11O
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
2724380
Created by
admin on Sat Dec 16 01:04:42 GMT 2023 , Edited by admin on Sat Dec 16 01:04:42 GMT 2023
|
PRIMARY | |||
|
DTXSID901021292
Created by
admin on Sat Dec 16 01:04:42 GMT 2023 , Edited by admin on Sat Dec 16 01:04:42 GMT 2023
|
PRIMARY | |||
|
300000023531
Created by
admin on Sat Dec 16 01:04:42 GMT 2023 , Edited by admin on Sat Dec 16 01:04:42 GMT 2023
|
PRIMARY | |||
|
39145-52-3
Created by
admin on Sat Dec 16 01:04:42 GMT 2023 , Edited by admin on Sat Dec 16 01:04:42 GMT 2023
|
PRIMARY | |||
|
PQ2TC3X11O
Created by
admin on Sat Dec 16 01:04:42 GMT 2023 , Edited by admin on Sat Dec 16 01:04:42 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ANHYDROUS->SOLVATE | |||
|
PARENT -> SALT/SOLVATE |
|